ALPHA ASCEND

DEAD

Serial Number

87575451

Owner

CSL BEHRING L.L.C.

Attorney

Scott Woldow

Filing Date

Aug 18, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ALPHA ASCEND Trademark

Serial Number: 87575451

ALPHA ASCEND is a trademark filed by CSL BEHRING L.L.C. on August 18, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 41 - Education & Entertainment

Education; providing of training; entertainment; sporting and cultural activities

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

CSL BEHRING L.L.C. (221 trademarks)

1020 FIRST AVENUE
KING OF PRUSSIA, PA 19406

Entity Type: 16

Legal Representation

Attorney of Record

Scott Woldow

166 trademarks filed View all →

Trademark Details

Filing Date

August 18, 2017

Registration Date

Not Registered

Published for Opposition

March 1, 2022

Goods & Services

publication of texts, books, and magazines featuring the results of clinical trials for pharmaceutical preparations; publication of printed matter relating to the results of clinical trials for pharmaceutical preparations for the treatment of A1P1 deficiency and emphysema

publication of texts, books, and magazines featuring the results of clinical trials for pharmaceutical preparations in the field of inflammatory and immune system disorders and deficiencies, blood and bleeding disorders, inhibitors and antibody disorders and deficiencies, and A1P1 deficiency and emphysema; publication of printed matter relating to the results of clinical trials for pharmaceutical preparations for the treatment of A1P1 deficiency and emphysema

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of inflammatory and immune system disorders and deficiencies, blood and bleeding disorders, inhibitors and antibody disorders and deficiencies, and A1P1 deficiencv and emphysema

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

May 30, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

May 29, 2023 ABN6

CORRECTED NOA E-MAILED

Nov 2, 2022 NOAC

NOTICE OF ALLOWANCE CORRECTION ENTERED

Nov 1, 2022 ICNA

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 1, 2022 AITU

TEAS POST PUBLICATION AMENDMENT RECEIVED

Oct 19, 2022 EPPA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 28, 2022 EXRA

SOU EXTENSION 1 GRANTED

Sep 26, 2022 EX1G

SOU EXTENSION 1 FILED

Sep 26, 2022 EXT1

SOU TEAS EXTENSION RECEIVED

Sep 26, 2022 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 26, 2022 NOAM

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 8, 2022 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 8, 2022 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 8, 2022 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 8, 2022 REAP

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 8, 2022 COAR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 1, 2022 NPUB

PUBLISHED FOR OPPOSITION

Mar 1, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 9, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 24, 2022 CNSA

EXAMINER'S AMENDMENT ENTERED

Jan 24, 2022 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 24, 2022 GNEN

EXAMINERS AMENDMENT E-MAILED

Jan 24, 2022 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jan 24, 2022 CNEA

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Jan 18, 2022 RCCK